Literature DB >> 427327

Species differences in the binding of compounds designed to fit a site of known structure in adult human haemoglobin.

C R Beddell, P J Goodford, D K Stammers, R Wootton.   

Abstract

1. Oxygen dissociation curves are reported for human haemoglobins A1, FII, FI, A1c and Raleigh (beta1 valine leads to acetylalanine) and for horse haemoglobin in the absence and presence of 2,3-diphosphoglycerate (DPG), or 4,4'-diformyl-2-bibenzyl oxyacetic acid, or the bisulphite addition compound of the latter. 2. These haemoglobins were selected because their amino acid sequences are different at the DPG receptor site of human adult deoxyhaemoglobin. 3. The size of the shifts of the dissociation curves are in the sequence expected from the postulated numbers of interactions made by each compound with each haemoglobin type, based on the assumption of a common receptor site for the three compounds. 4. Multiple linear regression analysis shows that the free energies of interaction of the compounds with the haemoglobins may be predicted, to a first approximation, by summing the number of ionic and covalent bonds predicted for each effector-receptor combination, a reversible covalent bond contributing about twice as much energy (-6.78 kJmol-1) as an ionic interaction (-3.14 kJmol-1).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427327      PMCID: PMC1668641          DOI: 10.1111/j.1476-5381.1979.tb07862.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The interaction of some bis-arylhydroxysulphonic acids with a site of known structure in human haemoglobin.

Authors:  F F Brown; P J Goodford
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

2.  The Bohr effect and combination with organic phosphates.

Authors: 
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

3.  Characterization of the ionizable groups interacting with anionic allosteric effectors of human hemoglobin.

Authors:  E Bucci; A Salahuddin; J Bonaventura; C Bonaventura
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

4.  Hemoglobin Raleigh (beta1 valine replaced by acetylalanine). Structural and functional characterization.

Authors:  W F Moo-Penn; K C Bechtel; R M Schmidt; M H Johnson; D L Jue; D E Schmidt; W M Dunlap; S J Opella; J Bonaventura; C Bonaventura
Journal:  Biochemistry       Date:  1977-11-01       Impact factor: 3.162

5.  Estimation of parameters in a multi-affinity-state model for haemoglobin from oxygen binding data in whole blood and in concentrated haemoglobin solutions.

Authors:  T Groth; L Garby; C H de Verdier
Journal:  J Mol Biol       Date:  1978-06-05       Impact factor: 5.469

6.  Cofactor binding and oxygen equilibria in haemoglobin.

Authors:  R E Benesch; R Benesch; R Renthal; W B Gratzer
Journal:  Nat New Biol       Date:  1971-12-08

7.  Stereochemistry of cooperative effects in haemoglobin.

Authors:  M F Perutz
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

8.  The interaction of some bis-aryl compounds with sites of known structure of human and horse haemoglobin [proceedings].

Authors:  P J Goodford
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

9.  Reciprocal interaction of hemoglobin with oxygen and protons. The influence of allosteric polyanions.

Authors:  R E Benesch; R Edalji; R Benesch
Journal:  Biochemistry       Date:  1977-06-14       Impact factor: 3.162

10.  The effect of 2,3-diphosphoglycerate on the oxygen dissociation curve of human haemoglobin.

Authors:  P J Goodford; F E Norrington; R A Paterson; R Wootton
Journal:  J Physiol       Date:  1977-12       Impact factor: 5.182

View more
  2 in total

1.  Designing the molecular future.

Authors:  Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2011-11-30       Impact factor: 3.686

2.  Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes.

Authors:  C R Beddell; P J Goodford; G Kneen; R D White; S Wilkinson; R Wootton
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.